Investigating how LRP4 affects Alzheimer's disease development
LRP4 deficiency in Alzheimer's disease development
This study is looking at a protein called LRP4 in brain cells to see how it helps clear out a substance linked to Alzheimer's disease, with the hope that understanding this process could lead to new ways to manage or prevent the condition for patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10875779 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of LRP4, a protein found in astrocytes, in the clearance of amyloid-β, which is crucial for the development of Alzheimer's disease. By studying how LRP4 interacts with other proteins and its expression in brain regions affected by Alzheimer's, the research aims to uncover new pathways that could help in managing or preventing the disease. Patients may benefit from insights gained into how to enhance amyloid clearance, potentially leading to new therapeutic strategies. The research involves laboratory studies and may include patient-derived samples to better understand the disease mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals aged 65 and older, particularly those with early signs of Alzheimer's disease or genetic predispositions such as the APOE ε4 allele.
Not a fit: Patients with other forms of dementia or those under 65 years of age may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve the clearance of amyloid-β and slow the progression of Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding the role of astrocytes in Alzheimer's disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: Xiong, Wen-Cheng — Case Western Reserve University
- Study coordinator: Xiong, Wen-Cheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.